For research use only. Not for therapeutic Use.
BLT-1 (Cat No.:I012774) is a potent and selective antagonist of the leukotriene B4 receptor 1 (BLT1), a key mediator in inflammation and immune response. By blocking the binding of leukotriene B4, BLT-1 inhibits its pro-inflammatory effects, including neutrophil recruitment and activation. This compound is valuable in researching inflammatory diseases such as asthma, rheumatoid arthritis, and inflammatory bowel disease. BLT-1 serves as a useful tool for studying leukotriene signaling pathways and exploring new therapeutic approaches to managing chronic inflammation and autoimmune disorders.
Catalog Number | I012774 |
CAS Number | 321673-30-7 |
Synonyms | Block lipid transport-1; 2-Hexyl-1-cyclopentanone thiosemicarbazone |
Molecular Formula | C12H23N3S |
Purity | ≥95% |
Target | HCV |
Storage | 2-8°C |
IUPAC Name | [(E)-(2-hexylcyclopentylidene)amino]thiourea |
InChI | InChI=1S/C12H23N3S/c1-2-3-4-5-7-10-8-6-9-11(10)14-15-12(13)16/h10H,2-9H2,1H3,(H3,13,15,16)/b14-11+ |
InChIKey | OWGUSBISUVLUJF-SDNWHVSQSA-N |
SMILES | CCCCCCC\1CCC/C1=N\NC(=S)N |